A detailed history of Tsfg, LLC transactions in Viatris Inc stock. As of the latest transaction made, Tsfg, LLC holds 707 shares of VTRS stock, worth $9,191. This represents 0.0% of its overall portfolio holdings.

Number of Shares
707
Previous 708 0.14%
Holding current value
$9,191
Previous $8,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$10.32 - $12.13 $10 - $12
-1 Reduced 0.14%
707 $8,000
Q2 2024

Jul 16, 2024

BUY
$10.05 - $12.02 $30 - $36
3 Added 0.43%
708 $8,000
Q1 2024

Apr 16, 2024

SELL
$11.27 - $13.53 $529 - $635
-47 Reduced 6.25%
705 $8,000
Q4 2023

Jan 23, 2024

SELL
$8.77 - $10.85 $306 - $379
-35 Reduced 4.45%
752 $8,000
Q3 2023

Oct 10, 2023

BUY
$9.59 - $11.35 $364 - $431
38 Added 5.07%
787 $8,000
Q2 2023

Jul 10, 2023

SELL
$9.02 - $10.29 $117 - $133
-13 Reduced 1.71%
749 $7,000
Q1 2023

Apr 21, 2023

BUY
$9.2 - $12.26 $27 - $36
3 Added 0.4%
762 $7,000
Q4 2022

Jan 19, 2023

SELL
$8.72 - $11.56 $348 - $462
-40 Reduced 5.01%
759 $8,000
Q3 2022

Oct 20, 2022

SELL
$8.48 - $11.13 $992 - $1,302
-117 Reduced 12.77%
799 $7,000
Q2 2022

Jul 13, 2022

SELL
$9.95 - $12.27 $308 - $380
-31 Reduced 3.27%
916 $10,000
Q1 2022

Apr 25, 2022

BUY
$9.81 - $15.4 $9 - $15
1 Added 0.11%
947 $10,000
Q4 2021

Feb 10, 2022

BUY
$12.09 - $14.68 $2,127 - $2,583
176 Added 22.86%
946 $13,000
Q3 2021

Oct 12, 2021

BUY
$13.25 - $15.13 $13 - $15
1 Added 0.13%
770 $10,000
Q2 2021

Jul 19, 2021

BUY
$12.97 - $16.15 $155 - $193
12 Added 1.59%
769 $11,000
Q1 2021

Apr 14, 2021

SELL
$13.59 - $18.54 $1,277 - $1,742
-94 Reduced 11.05%
757 $11,000
Q4 2020

Jan 20, 2021

BUY
$14.3 - $18.74 $12,169 - $15,947
851 New
851 $16,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Tsfg, LLC Portfolio

Follow Tsfg, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tsfg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tsfg, LLC with notifications on news.